BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 3901214)

  • 41. Imipenem-cilastatin in the treatment of methicillin-sensitive and methicillin-resistant Staphylococcus aureus infections.
    Fan W; del Busto R; Love M; Markowitz N; Cendrowski C; Cardenas J; Quinn E; Saravolatz L
    Antimicrob Agents Chemother; 1986 Jan; 29(1):26-9. PubMed ID: 3460521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Imipenem-cilastatin in the treatment of respiratory infections in patients with chronic airways obstruction.
    Wathen CG; Carbarns NJ; Jones PA; Millar A; Croughan MJ; Calder MA; Douglas NJ
    J Antimicrob Chemother; 1988 Jan; 21(1):107-12. PubMed ID: 3356618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
    Naber KG; Adam D; Bauernfeind A; Hönig E
    Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intramuscular imipenem/cilastatin in the treatment of mild and moderate infections.
    Wang C; Pappas F; Cook T
    Scand J Infect Dis Suppl; 1987; 52():32-9. PubMed ID: 3331041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinical study on imipenem/cilastatin sodium in the field of pediatrics].
    Minamitani M; Hachimori K; Kaneda K
    Jpn J Antibiot; 1986 Jul; 39(7):1817-27. PubMed ID: 3464780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Imipenem/cilastatin as secondary therapy for infections in cancer patients.
    Bodey GP; Rolston K; Jones P; Alvarez ME; Fainstein V; Steelhammer L
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():161-6. PubMed ID: 3469189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of bronchopulmonary infections in patients during artificial respiration with imipenem/cilastatin].
    Unertl K; Lenhart FP; Ruckdeschel G
    Immun Infekt; 1986 Nov; 14(6):229-31. PubMed ID: 3100428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical efficacy, safety and tolerability of intramuscular imipenem/cilastatin in the treatment of mild to moderate infections.
    Garau J; Casagrán A; Sánchez C; Matas E
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():181-3. PubMed ID: 3469192
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibacterial activity of imipenem: the first thienamycin antibiotic.
    Kropp H; Gerckens L; Sundelof JG; Kahan FM
    Rev Infect Dis; 1985; 7 Suppl 3():S389-410. PubMed ID: 3931196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of imipenem/cilastatin in patients with severe bacterial infections.
    Reutter FW
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():141-4. PubMed ID: 3469186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Imipenem/cilastatin in surgical intensive medicine].
    Wenk H; Schier H; Hollandt H; Valesky A
    Infection; 1986; 14 Suppl 2():S171-5. PubMed ID: 3759252
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections.
    Lode H; Wiley R; Höffken G; Wagner J; Borner K
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1491-6. PubMed ID: 3324956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies on imipenem/cilastatin sodium in pediatric field].
    Nagata K; Yokoyama M; Ohnishi A; Izumi Y
    Jpn J Antibiot; 1986 Jul; 39(7):1708-14. PubMed ID: 3464774
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol].
    Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M
    Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Imipenem/cilastatin: the first carbapenem antibiotic.
    Lyon JA
    Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imipenem/cilastatin in the treatment of obstetric and gynecologic infections.
    Berkeley AS; Freedman K; Hirsch J; Ledger WJ
    Am J Med; 1985 Jun; 78(6A):79-84. PubMed ID: 3859219
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Clinical experience with imipenem/cilastatin in the treatment of severe infections in general surgery].
    Mayer M; Brand J; Schlenkhoff D; Opferkuch W
    Infection; 1986; 14 Suppl 2():S160-3. PubMed ID: 3079549
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imipenem and cilastatin in acute osteomyelitis and suppurative arthritis. Therapy in infants and children.
    Freij BJ; Kusmiesz H; Shelton S; Nelson JD
    Am J Dis Child; 1987 Mar; 141(3):335-42. PubMed ID: 3544811
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imipenem/cilastatin therapy of bacteremia.
    Eron LJ
    Am J Med; 1985 Jun; 78(6A):95-9. PubMed ID: 3859221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.